Form 4: Director Mary Lynne Hedley Acquires Eli Lilly Shares Through Directors' Deferral Plan

Director Mary Lynne Hedley acquired 11.569 shares of Eli Lilly & Co (LLY) common stock at $857.2 per share through the Lilly Directors' Deferral Plan.

Summary

• On February 18, 2025, Mary Lynne Hedley, a director of Eli Lilly & Co, acquired 11.569 shares of common stock at a price of $857.2 per share.
• The acquisition was made through the Lilly Directors' Deferral Plan, where shares are deferred in lieu of cash compensation and will be settled in shares of common stock following separation from service.
• Following the transaction, Hedley directly owns 1,903.892 shares of Eli Lilly common stock.
• Hedley also indirectly owns 98 shares through a trust, but disclaims beneficial ownership except to the extent of her pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a director's stock acquisition through a deferral plan, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Directors often receive stock as part of their compensation or participate in deferred compensation plans.

Comparison to Industry Standards

• Director stock ownership is a common practice across the pharmaceutical industry.
• Companies like Pfizer (PFE) and Johnson & Johnson (JNJ) also have similar director compensation plans involving stock options and deferred stock units.
• The amount of stock owned by directors varies depending on their tenure, compensation structure, and individual investment decisions.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency regarding director ownership, which can influence investor confidence.

Key Dates